Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001788542-22-000006
Filing Date
2022-11-17
Accepted
2022-11-17 17:30:33
Documents
1
Period of Report
2022-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166872420553318.html 4  
1 FORM 4 wf-form4_166872420553318.xml 4 3865
  Complete submission text file 0001788542-22-000006.txt   5236
Mailing Address 233 WILSHIRE BOULEVARD SUITE 280 SANTA MONICA CA 90401
Business Address
Mottiwala Aziz (Reporting) CIK: 0001788542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 221399730

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)